These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8066636)

  • 1. Hematopoietic stem cell chimerism: relationships between degree of chimerism, T cell clonal deletion, and graft survival.
    Taniguchi H; Jinzenji Y; Fukao K; Nakauchi H
    Transplant Proc; 1994 Aug; 26(4):1966-8. PubMed ID: 8066636
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of intrathymic mixed chimerism for maintenance of skin allograft tolerance across fully allogeneic (entire major H-2 plus multiminor histocompatibility) antigen barriers in mice.
    Eto M; Nishimura Y; Kong YY; Maeda T; Nomoto K; Kumazawa J; Nomoto K
    Transplant Proc; 1994 Apr; 26(2):841-4. PubMed ID: 8171683
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 6. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
    Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
    J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice.
    De Fazio SR; Kowolenko M; Monaco AP; Gozzo JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):547-8. PubMed ID: 2856297
    [No Abstract]   [Full Text] [Related]  

  • 10. Extent of chimerism determines the mode of tolerance in mixed bone marrow chimeras.
    Taniguchi H; Yuzawa K; Takada Y; Otsuka M; Fukao K; Nakauchi H
    Transplant Proc; 1997; 29(1-2):1193-5. PubMed ID: 9123268
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged skin allograft survival in Scid mice reconstituted with isogeneic bone marrow stem cell antigen-1-positive cells and thymus tissue.
    Gao Z; Tibbles L; Yilmaz S; Gao Y; MacDonald A
    Transplant Proc; 2005 Jun; 37(5):2300-2. PubMed ID: 15964404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
    Koch U; Choksi S; Marcucci L; Korngold R
    J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance.
    Wekerle T; Nikolic B; Pearson DA; Swenson KG; Sykes M
    Transpl Int; 2002 May; 15(5):248-53. PubMed ID: 12012046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 18. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene.
    Sachs DH; Bodine DM; Moulton AD; Pearson DA; Nienhuis AW; Sykes M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):348-9. PubMed ID: 8438329
    [No Abstract]   [Full Text] [Related]  

  • 20. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.
    Hase T; Chargui J; Inori F; Yoshimura R; Sembeil R; Nakatani T; Touraine JL
    Transplant Proc; 2005; 37(1):287-8. PubMed ID: 15808621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.